The company is shuttering the program and focusing on other compounds in its pipeline after CRS-207 failed in studies. Source: BioSpace

The approval for EGPA is based on results from the pivotal, 52-week, Phase III MIRRA1 study, conducted as a collaboration between GSK and the NIAID, part of the US NIH.…

One of the biggest concerns has been the loss of the R&D tax credit, which incentivizes companies, including life science firms, to support research. Source: BioSpace

The ZUMA-3 study results were presented in an oral session at the Annual Meeting of the ASH in Atlanta. Source: BioSpace

The deal is expected to close in the first quarter of 2018. Source: BioSpace

Dr. Hillan will remain on, and Mr. Wise will join, the Company’s Board of Directors. Source: BioSpace

As Sanofi grapples with the fallout from its Dengue vaccine, the termination of its late-stage C. diff vaccine and falling short of its third quarter expectations, company investors are getting…

Admelog is a rapid-acting insulin similar to Humalog, another insulin lispro 100 Units/mL, currently approved in the U.S. Source: BioSpace

In investment jargon, a "unicorn" has at least two meanings. Source: BioSpace

Teva may be passing out more pink slips as the company looks to cut up to 10,000 jobs in order to save up to $2B in costs over the next…